News
Analyzing single-cell RNA sequencing (scRNA-seq) data is crucial for understanding complex biological processes and disease ...
MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC-seq ...
Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are ...
Single-cell RNA sequencing (scRNA-seq) has revolutionized modern biology, allowing scientists to study the expression of ...
The hippocampus is an important brain region known to support various cognitive (i.e., mental) processes, including the ...
Scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments. Even cells ...
The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of genetically ...
Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results